Sustained-release diclofenac potassium-loaded solid lipid microparticle based on solidified reverse micellar solution: In vitro and in vivo evaluation

Journal of Microencapsulation

Volumn 30, Issue 4, 2013, Pages 335-345

  Chime, Salome Amarachi ^a   Attama, Anthony Amaechi ^a   Builders, Philip F ^b   Onunkwo, Godswill C ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b NATIONAL INSTITUTE FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (Nigeria)

Author keywords

Diclofenac potassium; SLMs; SRMS; Sustained release; Ulcerogenicity

Indexed keywords

DICLOFENAC POTASSIUM; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; SORBITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SCREENING; ENCAPSULATION; FREEZE DRYING; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLUID; MICELLE; NONHUMAN; PARTICLE SIZE; PAW EDEMA; RAT; SUSTAINED DRUG RELEASE; ULCEROGENESIS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; FEMALE; LIPIDS; MALE; MICELLES; RATS; RATS, WISTAR;

EID: 84877300645     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2012.726284     Document Type: Article

References (29)

1. Anosike AC, Onyechi O, Ezeanyika LUS, Nwuba MM. Anti-inflammatory and anti-ulcerogenic activity of the ethanol extract of ginger (Zingiber officinale). Afr J Biochem Res, 2009;3(12):379-84
2. Attama AA, Muller-Goymann CC. A critical study of novel physically structured lipid matrices composed of a homolipid from Capra hircus and theobroma oil. Int J Pharm, 2006;322:67-78 (Pubitemid 44331526)
3. Attama AA, Muller-Goymann CC. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Int J Pharm, 2007;334:179-89 (Pubitemid 46400318)
4. Attama AA, Okafor CE, Builders PF, Okorie O. Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium. Drug Deliv, 2009;16:448-616
5. Attama AA, Schicke BC, Mu?ller-Goymann CC. Further characterization of theobroma oil beeswax admixtures as lipid matrices for improved drug delivery systems. Eur J Pharm Biopharm, 2006;64:294-306 (Pubitemid 44585215)
6. British Pharmacopoeia Commission. 2009. British pharmacopoeia 2009, Vol. I and II. London: The Commission Office, pp. 1889-95
7. Chung-Chin M, Santos JL, Oliveira EV, Blau L, Menegon RF, Peccinini RG. Synthesis, ex-vivo and in vitro hydrolysis study of an indoline derivative designed as anti-inflammatory with reduced gastric ulceration properties. Molecules, 2009;14:3187-97
8. El-Kamel HA, Al-Fagih MI, Alsarra AI. Testosterone solid lipid microparticles for transdermal drug delivery formulation and physicochemical characterisation. J Microencapsul, 2007;24(5):457-75
9. Fouad EA, El-badry M, Mahrous GM, Alsarra IA, Alashbban Z, Alanazi FK. In vitro investigation for embedding dextromethorphan in lipids using spray drying. Digest J Nanomat Biostruct, 2011;6(3):1129-39
10. Friedrich I, Muller-Goymann CC. Characterization of solidified reverse micellar solutions (SRMS) and production development of SRMS based nanosuspensions. Eur J Pharm Biopharm, 2003;56:111-19 (Pubitemid 36802054)
11. Friedrich I, Reichl S, Muller-Goymann CC. Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS). Int J Pharm, 2005;305:167-75 (Pubitemid 41562227)
12. Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 1963;52:1145-9
13. Jaspart S, Bertholet P, Piel G, Dogne JM, Delattre L, Evrad B. Solid lipid microparticles as sustained release system for pulmonary drug delivery. Eur J Pharm Biopharm, 2007;65:47-56 (Pubitemid 44827691)
14. Jaspart S, Piel G, Delatte L, Evrad B. Solid lipid microparticles: Formulation, preparation, characterization, drug release and applications. Expert Opin Drug Deliv, 2005;2:75-87 (Pubitemid 40123884)
15. Khopade AJ, Jain NK. Long circulating lipospheres targeted to inflamed tissue. Pharmazie, 1997;52:165-6 (Pubitemid 27101353)
16. Lichtenberger LM. The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol, 1995;57:565-83
17. Ofoefule SI, Chukwu A. 2002. Sustained release dosage forms: Design and evaluation of oral products. In: Ofoefule SI, ed. Text book of pharmaceutical technology and industrial pharmacy. Lagos, Nigeria: Samakin Enterprises, pp. 94-120
18. Parez GRM. Anti-inflammatory activity of Ambrosia artemisaefolia and Rheo spathacea. Phytomedicine, 1996;3(2):163-7
19. Pilaniya K, Pilaniya U, Saharan S, Saharan P, Chandrawanshi KH. Biodegradable solid lipid microparticles loaded with diltiazem hydrochloride for oral delivery: Preparation and in-vitro/in-vivo evaluation. J Drug Deliv Ther, 2011;1(1):48-59
20. Rawat SM, Singh D, Saraf S. Formulation optimization of controlled delivery systems for antihypertensive peptides using response surface methodology. Am J Drug Discovery Dev, 2011;1(3):174-87
21. Ritger PL, Peppas NA. A simple equation for description of solute release: I. Fickian and non-Fickian release from non swellable device in the form of slabs, spheres, cylinders and discs. J Cont Rel, 1987;5:23-36 (Pubitemid 17106643)
22. Sanna V, Kirschvink N, Gustin P, Gavini E, Roland I, Delattera L, Evrad B. Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS Pharm Sci Technol, 2004; 5(2):17-23
23. Schneeweis A, Muller-Goymann CC. Controlled release of solid-reversedmicellar-solution (SRMS) suppositories containing metoclopramide-HCl. Int J Pharm, 2000;196:193-6 (Pubitemid 30105741)
24. Singh J, Gupta S, Kaur H. Prediction of in vitro drug release mechanisms from extended release matrix tablet using SSR/SR2 techniques. Trends App Sci Res, 2011;6(4):400-9
25. Suresh G, Manjunath K, Venkateshwarlu V, Satyanarayana V. Preparation, characterization and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS Pharm Sci Technol, 2007;8(1): E162-70
26. Umeyor EC, Kenechukwu FC, Ogbonna JD, Chime SA, Attama AA. Preparation of novel solid lipid microparticles loaded with gentamicin and its evaluation in vitro and in vivo. J Microencapsul, 2012;29(3): 296-307
27. Wallace JL. Pathogenesis of NSAID ulceration. Bail Clin Gastro, 2000;14(1): 147-59
28. Winter ER, Risley EA, Nuss GU. Carrageenan-induced oedema in hind paw of rats as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med, 1962;111:544-7
29. Winter EA, Risley EA, Nuss GU. Anti-inflammatory and antipyretic activities of indomethacin. J Pharmacol Exp Ther, 1963;141:367-76